New concepts in atopic dermatitis;Nuevos conceptos en dermatitis atópica

Revista Alergia Mexico

Volumn 48, Issue 1, 2001, Pages 15-24

  Vaquez S ^a   Modesto Orea, S ^a   Graciela, F S ^a  

^a HOSPITAL REGIONAL LIC ADOLFO LÓPEZ MATEOS   (Mexico)

Author keywords

Atopic dermatitis; Thalidomide; Transfer factor

Indexed keywords

CHEMOTACTIC FACTOR; EOTAXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; RANTES; THALIDOMIDE; TRANSFER FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; IMMUNOTHERAPY; MAST CELL; MEDIATOR RELEASE; PROTEIN EXPRESSION; PRURITUS; REMISSION; REVIEW;

EID: 84862715335     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Atopic dermatitis
2. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood
3. Pathogenesis of atopic dermatitis
4. Diagnostic features of atopic dermatitis
5. Pathogenesis of atopic dermatitis
6. Immunopathogenesis and treatment of atopic dermatitis
7. Role of antigen-induced cytokine release in atopic pruritus
8. The clinical spectrum of atopic dermatitis
9. Itching and the atopic skin
10. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
11. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients
12. Effect of stress on atopic dermatitis: Investigation in patients after the great Hanshin earthquake
13. Month of birth and prevalence of atopic dermatitis in schoolchildren: Dry skin in early infancy as a possible etiologic factor
14. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis
15. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: Signs of subset expansion and stimulation
16. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: Soluble L-selectin levels indicate disease severity
17. Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear cells in infants with atopic dermatitis
18. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis
19. GM-CSF inhibition of monocyte apoptosis contributes to the chronic monocyte activation in atopic dermatitis
20. IgE in asthma and atopy: Cellular and molecular connections
21. Chemokines and allergic disease
22. Lymphocyte homing and homeostasis
23. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis
24. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration
25. Mechanisms of eosinophil-associated inflammation
26. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: Correlation with disease activity
27. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
28. In vivo expression of cytokine receptor mRNA in atopic dermatitis
29. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis
30. Eotaxin and monocyte chemoattractant protein (MCP)-4 mRNA expression in acute versus chronic atopic dermatitis
31. Enhanced expression of eotaxin and CCR3 in atopic dermatitis
32. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory to T cells
33. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic: Dermatitis
34. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes
35. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis
36. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics
37. Selective expression of an interleukin-12 receptor component by human T helper 1 cells
38. IL-18: A Th1-inducing, proinflammatory cytokine and new member of the IL-1 family
39. Identifying genes predisposing to atopic dermatitis
40. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
41. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
42. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: A potential role in the modulation of IgE synthesis
43. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis
44. Dendritic cells in allergy
45. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells
46. IL-4 induces the intracellular expression of the a chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells
47. Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management
48. Food allergy, I: Immunopathogenesis and clinical disorders
49. Prevalence of IgE-mediated food allergy among children with atopic dermatitis
50. T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis
51. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens
52. The role of inhalant allergens in atopic dermatitis
53. Causation of eczema urticaria, and angioneurotic edema by proteins other than those derived from foods
54. Studies in atopic dermatitis, IV: Importance of seasonal inhalant allergens, especially ragweed
55. Coprinus comatus (shaggy cap) is a potential source of aeroallergen that may provoke atopic dermatitis
56. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren
57. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis
58. Evaluation of the staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis
59. Evidence for a disease promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis
60. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production
61. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens
62. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen
63. Application of staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism
64. Autoallergy: A pathogenetic factor in atopic dermatitis?
65. Molecular characterization of an autoallergen, Hom s 1, identified by serum IgE from atopic dermatitis patients
66. Update on therapy of atopic dermatitis
67. The manegement of moderate to severe atopic dermatitis in adults with topical fluticasone propionate
68. Prospective, long-term safety evaluation of the H1-receptor antagonist cetirizine in very young children with atopic dermatitis, ETAC Study Group: Early treatment of the atopic child
69. Phototherapy for atopic dermatitis
70. Aziothioprine in dermatology: A survey of current practice in the U.K.
71. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease
72. A pharmacogenetic basis for the safe and effective use of azothioprine and other thiopurine drugs in dermatologic patients
73. Role of interferon-gamma in immune cell regulation
74. Recombinant interferon-gamma therapy for atopic dermatitis
75. Intracellular interlcukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy resistant atopic dermatitis
76. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
77. High dose intravenous immunoglobulin in atopic dermatitis and hyper IgE syndrome
78. Immunosuppressive effect of mycophenolic acid
79. Mycophenylate mofetil in autoimmune and inflammatory skin disorders
80. Rediscovering mycophenolic acid: A review of its mechanism, side effects, and potential uses
81. Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents
82. The leukotriene antagonist Zafirlukast as a therapeutic agent for atopic dermatitis
83. Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: Correlation with clinical improvement
84. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin
85. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis
86. Treatment of atopic dermatitis: Role of tacrolimus ointment as a topical noncorticosteroidal therapy
87. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children: Pediatric tacrolimus study group
88. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: In vitro pharmacology
89. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis
90. Alergia,asma e Inmunologia PediatricasDesordenes inmunológicos y el resurgimiento de la talidomida
91. Antitumor activity of thalidomide in refractory multiple myeloma
92. Thalidomide and derivatives: Immunolgical investigations of tumour necrosis factor-alpha (TNF-alfa) inhibition suggest drugs capable of selective gene regulation
93. Factor de transferencia en dermatitis atómica moderada y severa
94. Transfer Factor
95. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma
96. Effects of an antibody to interleukin-5 in a monkey model of asthma
97. Interleukin-4 receptor in moderate atopic asthma
98. Treatment of allergic asthma with monoclonal anti-IgE antibody
99. Analysis of Chinese herbal creams prescribed for dermatological conditions
100. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis